Idris Arslan
ABSTRACT
Natural product-based hybrid molecules have recently revolutionized promising anticancer results. Triterpenoids represent a wide-spread class of secondary metabolites with a carbon skeleton which contains six isoprene units by the cyclization of squalene. Molecular optimization is frequently necessary for improvement on target specificity, lower toxicity, potency, and stability as well. Lately, to improve the molecular potency some synthetic toolboxes which can access the molecular diversity have been developed. This review showcases structural modification of triterpenoids and their anti-cancer efficacy compared to original compounds.
- Li JW, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science. 2009 325(5937):161-165.Google Scholar
- Arslan I. 2014. Simenoside A, a new triterpenoid saponin from Gypsophila simonii Hub.-Mor. Chem Biodivers. 2014 Mar;11(3):445-50.Google Scholar
- Arslan, I., Cenzano, A.M., 2021. Characterization of Triterpene Saponins from Gypsophila arrostii by Electrospray Ionization Ion Trap Multiple-Stage Mass Spectrometry. Revista Brasileira de Farmacognosia. 31, 107–111.Google ScholarCross Ref
- Arslan, I., Cenzano, A.M. 2020. N-triterpene saponins in cancer therapy: A review of mode of action. Revista Brasileira de Farmacognosia, 2020, 30(1): 1–6.Google ScholarCross Ref
- Laszczyk MN, 2009. Pentacyclic triterpenes of lupane, oleanane and ursane group as tools in cancer therapy. Planta Medica. 75:1549-1560.Google ScholarCross Ref
- Ali-Seyed M, Jantan I, Vijayaraghavan K, Bukhari SNA. 2016. Betulinic acid: recent advances in chemical modification, effective delivery, and molecular mechanisms of a promising anticancer therapy. Chem Biol Drug Des. 87:517-536.Google ScholarCross Ref
- Choudhary S, Singh PK, Verma H, Singh H, Silakari O. 2018. Success stories of natural product-based hybrid molecules for multi-factorial diseases. Eur. J. Med. Chem. 151:62-97.Google ScholarCross Ref
- Majeed R, Sangwan PL, Chinthakindi PK, Khan I, Dangroo NA, Thota N, Hamid A, Sharma PR, Saxena AK, Koul S. Synthesis of 3-O-propargylated betulinic acid and its 1,2,3-triazoles as potential apoptotic agents, European Journal of Medicinal Chemistry, 2013, 63:-792.Google ScholarCross Ref
- Zhang X, Zhang S, Zhao S, Wang X, Liu B, Xu H. Click chemistry in natural product modification. Frontiers in Chemistry. 2021. 9:1-29.Google Scholar
- Xiao AJ, Miller BW, Huntington JA, Nicolau DP. Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic‐derived dose justification for phase 3 studies in patients with nosocomial pneumonia. The Journal of Clinical Pharmacology, 2016; 56(1), 56-66.Google Scholar
- Guo L, Luo L, Ju R, Chen C, Zhu L, Li J,Yu X, Ye C, Zhang, D. Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases. European Journal of Pharmacology, 2015; 746, 14-21.Google Scholar
- Choi HG, Jun HW, Kim DD, Sah H, Yoo BK, Yong CS. Simultaneous determination of cefatrizine and clavulanic acid in dog plasma by HPLC. Journal of pharmaceutical and biomedical analysis, 2004; 35(1), 221-231.Google Scholar
- Panebianco M, Prabhakar H, Marson AG. Rufinamide add‐on therapy for refractory epilepsy. Cochrane Database of Systematic Reviews, 2018; (4). CD011772.Google Scholar
- Pettit GR, Melody N, Hempenstall F, Chapius JC, Groy TL, Wiliams L. 2014. Antineoplastic Agents. 595. Structural Modifications of Betulin and the X-ray Crystal Structure of an Unusual Betulin Amine Dimer1. 77(4):863-872.Google Scholar
- Alcazar, W. López, A.S., Alakurtti, S., Tuononen, M-L., Yli-Kauhaluoma, J. & Ponte-Sucre, A. 2014. Betulin derivatives impair Leishmania braziliensis viability and host–parasite interaction. Bioorg. Med. Chem. 22, 6220–6226.Google ScholarCross Ref
- Wert, L. Alakurtti, S., Corral, M.J., Sanchez-Fortun S., Yli-Kauhaluoma, J. & Alunda, J.M. 2011. Toxicity of betulin derivatives and in vitro effect on promastigotes and amastigotes of Leishmania infantum and L. donovani. J. Antibiot. 64, 475–481.Google ScholarCross Ref
- Yang H, Ping Dou Q. Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer. Current drug targets, 2010; 11(6), 733-744.Google Scholar
- Pollier J, Goossens A.2012. Oleanolic acid. Phytochemistry. 77:10-5.Google ScholarCross Ref
- Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol. 1995. 49(2):57-68.Google Scholar
- Sporn MB, Liby KT, Yore MM, Fu L, Lopchuk JM, Gribble GW. New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J Nat Prod. 2011;74(3):537-545.Google Scholar
- Qian Y, Xin Z, Lv Y, Wang Z, Zuo L, Huang X, Li Y and Xin HB. 2018. Asiatic acid suppresses neuroinflammation in BV2 microglia via modulation of the Sirt1/NF-κB signaling pathway. Food Funct., 2018, 9, 1048-1057.Google ScholarCross Ref
- Lee YS, Jin DQ, Kwon EJ, Park SH, Lee ES, Jeong TC, Nam DH, Huh K, Kim JA. Asiatic acid, a triterpene, induces apoptosis through intracellular Ca2+ release and enhanced expression of p53 in HepG2 human hepatoma cells. Cancer Lett. 2002 186(1):83-91.Google Scholar
- Huang RZ, Liang GB, Li MS, Fang YL, Zhao SF, Zhao MM, Liao ZX, Sun J, Wang HS. 2019. Synthesis and discovery of asiatic acid based 1,2,3-triazoles derivatives as antitumor agents blocking NF-KB activation and cell migration. Med. Chem. Commun., 2019,10, 584-597.Google ScholarCross Ref
- Ma CM, Shao-Qing Cai, Jing-Rong Cui, Rui-Qing Wang, Peng-Fei Tu, Masao Hattori, Mohsen Daneshtalab, The cytotoxic activity of ursolic acid derivatives, European Journal of Medicinal Chemistry, Volume 40, Issue 6, 2005, Pages 582-589.Google ScholarCross Ref
- Rashid S, Dar BA, Majeed R, Hamid A, Bhat BA. Synthesis and biological evaluation of ursolic acid-triazolyl derivatives as potential anti-cancer agents. Eur. J. Med. Chem. 2013. 66:238-245.Google Scholar
- Takahashi H, Nguyen BCQ, Uto Y, Shahinozzaman M, Tawata S, Maruta H. 2, 3-Triazolyl esterization of PAK1-blocking propolis ingredients, artepillin C (ARC) and caffeic acid (CA), for boosting their anti-cancer/anti-PAK1 activities along with cell-permeability, Drug Discov 2017; 104–109.Google Scholar
- Dong J, Sharpless KB, Kwisnek L, Oakdale JS, Fokin VV. SuFEx-based synthesis of polysulfates. Angew. Chem. Int. Ed. 2014, 53 (36):9466-9470.Google Scholar
- Kim, D.S.H.L., Pezzuto, J.M. & Pisha, E. Synthesis of betulinic acid derivatives with activity against human melanoma. Bioorg. Med. Chem. Lett. 8, 1707–1712 (1998).Google Scholar
Index Terms
- Success stories of triterpenoid-based hybrid molecules as new promising anticancer agents: Triterpenoid-driven analogs
Recommendations
Knowledge-driven design and optimization of potent symmetric anticancer molecules: A case study on PKM2 activators
Abstract BackgroundPyruvate kinase M2 (PKM2) is preferentially expressed as a low-activity dimer over the active tetramer in proliferating tumor cells, resulting in metabolic reprogramming to achieve high energy requirements and ...
Graphical abstractDisplay Omitted
Highlights- Knowledge-based drug discovery encourages the design of specific and potent compounds.
Computational identification of novel histone deacetylase inhibitors by docking based QSAR
Histone deacetylases (HDACs) are enzymes that modify chromatin structure and contribute to aberrant gene expression in cancer. A series compounds with well-assigned HDAC inhibitory activity was used for docking based 3D-QSAR analysis. The 3D-QSAR ...
A promising in silico protocol to develop novel PPARγ antagonists as potential anticancer agents: Design, synthesis and experimental validation via PPARγ protein activity and competitive binding assay
AbstractPeroxisome proliferator-activated receptor gamma (PPARγ), a member of the nuclear receptor superfamily is an excellent example of targets that orchestrates cancer, inflammation, lipid and glucose metabolism. We report a protocol for ...
Graphical AbstractDisplay Omitted
Highlights- 3D QSAR models are generated based on a large and diverse set of PPARγ antagonist ligands by the HYPOGEN algorithm.
Comments